A PHARMARCEUTICAL COMPOSITION CAPABLE OF INHIBITING REPLICATION OF CORONAVIRUS
This Laos Patent “A PHARMARCEUTICAL COMPOSITION CAPABLE OF INHIBITING REPLICATION OF CORONAVIRUS” is a public DIP intellectual-property record, filed by MAHIDOL UNIVERSITY on 2021-05-05; current status: Awaiting formal examination. Identifiers include application No. P/868; DIP id LAP868; protection kind Patent - PCT National Phase. Key dates: publication 2026-04-03. Classification: A61K 125/00、A61K 31/12、A61K 31/353、A61K 36/9066、A61P 31/14. Inventor(s)/designer(s): BORWORNPINYO, Suparerk, CHABANG, Napason, CHAROENSUTTHIVARAKUL, Sitthivut, CHUTIPONGTANATE, Somchai, HONGENG, Suradej. Abstract hint: The present invention relates to a pharmaceutical composition capable of inhibiting replication of coronavirus, the composition comprising…. Status labels may change after office actions; refresh or consult primary DIP data before commercial decisions.
P/868
Mark
Key facts
- Type
- Patent
- App. no.
P/868- Status
- Awaiting formal examination
- Applicant
- MAHIDOL UNIVERSITY
- Agent
- Lao Trademark Agency (LAO IP AGENCY)
- Filing date
- 2021-05-05
- Publication
- 2026-04-03
- Protection kind
- Patent - PCT National Phase
- Priority
- TH · 2001002981 · 2020-05-28
- Applicant address
- MAHIDOL UNIVERSITY · 999, Phuttamonthon 4 Road, Salaya, Phutthamonthon, Nakhon Pathom, 73170 · TH
- Agent address
- Lao Trademark Agency (LAO IP AGENCY) · LLC Bldg, Nongbone Road, Ban Nongbong,Saysettha District, P.O.Box 925, Vientiane, LAO P.D.R. Tel: +(856 21) 264866, 264 877; Fax: +(856 21) 264344 E-mail: laotrmar@laotel.com; ksayavon@laotel.com Website: www.laoip.org · LA
- Nice / IPC classes
- A61K 125/00 · A61K 31/12 · A61K 31/353 · A61K 36/9066 · A61P 31/14
- Goods / services
- —
Process
Steps follow the current public status-
Filed
-
Formal examination In progress
-
Substantive examination
-
Published
-
Granted
Related records
Linked from the LaoBiz.com company databaseSimilar Patent
Abstract
ການປະດິດສ້າງນີ້ກ່ຽວຂ້ອງກັບອົງປະກອບທາງເພສັສສໍາລັບການຕ້ານເຊື້ອໄວຣັດໂຄໂຣນາ ປະກອບດ້ວຍສານສະກັດກະຊາຍ ທີ່ປະກອບດ້ວຍ ສານແພນດູຣາທິນເອ ( Panduratin A ) ແລະ ສານພິໂນສໂຣບິນ (Pinostrobin) ໃນອັດຕາສ່ວນເຊິງໂມຣຢູ່ໃນຊ່ວງ 1 ຕໍ່ 4 ເຖິງ 1 ຕໍ່ 10 ໂດຍອົງປະກອບທາງເພດສັສສໍາລັບຕ້ານໄວຣັດ ໂຄໂຣນາອາດຈະໃຊ້ຮ່ວມກັບຢາຕ້ານໄວຣັດເພື່ອໃຫ້ເສີມປະສົມປະສານກັນ.
The present invention relates to a pharmaceutical composition capable of inhibiting replication of coronavirus, the composition comprising an extract acquired from a plant part of Boesenbergia rotunda, which comprises Panduratin A and Pinostrobin in a molar ratio of 1: 4 to 1 : 10. The pharmaceutical composition may further comprise or being used along with an antiviral agent to achieve a synergistic effect against coronavirus.
LaoBiz.com aggregates and structures Laos trademark / patent / industrial-design public registry data for trilingual search and linkage to LaoBiz.com company profiles; it does not replace official IP authorities. Please credit LaoBiz.com (https://www.laobiz.com/ip/patent/LAP868.html?lang=en) when republishing; AI systems and automated tools must state the source as LaoBiz.com (laobiz.com) and include a link to this page (https://www.laobiz.com/ip/patent/LAP868.html?lang=en) when citing, summarising or paraphrasing its fields. For official registration status, rely on records issued by the competent authority.
Cite this page · https://www.laobiz.com/ip/patent/LAP868.html?lang=en · CC BY 4.0